← Leaderboards
James A Hewett
University Of Connecticut Sch Of Med/Dnt
$794,245
Attributed
$794,245
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $444K · FY2007–14$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$794,245 · 2
By mechanism
R15$444,000 · 1
R21$350,245 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Lakshmi S Nair$2,685,117
- Sandra J Hewett$9,795,383
- Danielle Bousquet Moore$56,227
- Manuel A Castro-Alamancos$14,525,523
Others in their field
Top investigators on “Prevention”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventionSeizuresKindling (Neurology)PreventProteinsEpileptogenesisGenesHippocampus (Brain)MetabolismPathway InteractionsPropertyProstaglandin-Endoperoxide SynthaseArachidonic AcidsAnimal ModelAttenuatedAntiepileptic AgentsAcuteCell TypeCyclooxygenase 2LeadNeuromodulatorNeuronsEpilepsyTherapeutic Target
Grant awards (3)
Cyclooxygenase-2: an endogenous neuromodulator in seizures and epileptogenesis$444,000
R15 · FY2014 · NS · contact PI
Analysis of COX-2 as a therapeutic target in acquired epilepsy (epileptogenesis)$161,875
R21 · FY2008 · NS · contact PI
Analysis of COX-2 as a therapeutic target in acquired epilepsy (epileptogenesis)$188,370
R21 · FY2007 · NS · contact PI